ClinicalTrials.gg
Active, not recruitingNCT07512765ANK-PROSUpdated Apr 6, 2026

Ankyloglossia and Its Effects on Breastfeeding, Feeding and Speech Disorders. A Prospective Study From Birth to 4 Years of Age.

An observational study in Ankyloglossia, Breastfeeding and Breastfeeding Self-Efficacy, sponsored by Erasme University Hospital. Active, not recruiting at 1 site in Belgium. Open to participants aged 1 Day to 5 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-06.

Sponsored by Erasme University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
348
Ages
1 Day to 5 Days
Sex
All
01

Study summary

The diagnosis of ankyloglossia (restrictive lingual frenulum) and the number of frenotomies in infants have sharply increased, raising concerns among the medical community and the ONE. While some studies suggest benefits of frenotomy on breastfeeding, all emphasize the lack of consensus regarding the definition, diagnosis, and classification of ankyloglossia, as well as the scarcity of prospective data on its impact on breastfeeding, feeding, occlusion, and speech.

This prospective study aims to determine whether lingual frenulum characteristics influence early breastfeeding difficulties and duration, as well as later feeding, occlusion, and speech outcomes. Breastfed newborns are followed from the first days of life (T1) to age 4 years (T7). During the first 3 months, tongue mobility, frenulum characteristics, breastfeeding, maternal pain, and complications are assessed. Several clinical tools are compared to identify the most reliable ones. Frenulum length is measured using calibrated photographs.

Phone follow-ups at 6 months, 1 and 2 years assess feeding outcomes; speech and occlusion are evaluated at 4 years.

This project could provide objective data to guide clinicians in evaluating ankyloglossia and making informed frenotomy decisions, improve breastfeeding support, and help parents make evidence-based choices.

Read the detailed description

Design: Prospective longitudinal study. The study was approved by the Ethics Committee of Erasme Hospital on May 4, 2022 (Reference : P2022/167/B4062021000404).

Newborns and their mother are recruited at Maternity Ward of Erasme Hospital, HUB Belgium. The dyads are then been followed up to the age of 4 years through clinical examinations, questionnaires and phone calls. Assessments at 6 weeks and 3 months of age are conducted to analyze early outcomes.

Sample size:

Sample size was calculated as follows, based on the calculation of Souza-Oliveira et al.20 : we considered 4.8% incidence of ankyloglossia in newborns based on the study by Messner et al. (2000), a margin of error of 3.0%, and 99.0% of confidence interval. The minimum sample size was 337. From 2022 to 2024, we have already completed our sample recruiting 348 in order to compensate for possible losses in the follow-up.

Primary outcomes: pain during breastfeeding (VAS and Mc Gill Pain Questionary), breastfeeding duration (days), presence of crackled nipples, engorgement, mastitis, nipple bleeding, abscess (breastfeeding complications).

Secondary outcomes:

  • frenulum length and width at birth, 1 month, 3 months of life.
  • breastfeeding assessment scales: LATCH score, Bristol Breastfeeding Assessment Tool (BBAT), NOMAS (Neonatal Oral-Motor Assessment Scale), Infant Breastfeeding Assessment Tool (IBFAT), Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF).
  • Ankyloglossia scales: Hazelbaker Assessment Tool for Lingual Frenulum Function (HATLFF)1, the Tongue-tie and Breastfed Babies (TABBY) scale2, the Lingual Frenulum Protocol with Scores for Infants (LFPI)4, the Coryllos scale3 and the Baxter Infant Examination Form21.
  • Muscle tension and joint mobility as manually assessed by an osteopath, and data's from The Myoton Pro (© 2016 Myoton AS), a non-invasive device designed to assess tone, stiffness, elasticity, relaxation time and tissue deformation, on the following muscles: sternocleidomastoid, trapezius, mylohyoid.

AMG-Pediatrics SCIENTIFIC SECTION- 4

Conduction of the Research :

The study has been conducted as follows:

T1 : between 1 and 5 days of the newborn's life, at the postnatal ward, a duo of an osteopath and a pediatrician performed examinations to assess:

A. Newborn's assessment:

  1. Neurological status: evaluated using the Amiel-Tison and Gosselin Neurological Assessment from Birth to 6 Years (ENAT) scale, as part of the standard pediatric examination
  2. Oral anatomy and function: The baby's frenulum is assessed using multiple standardized scales (HATLFF1, TABBY2, Coryllos3, LFPI4, and Baxter Infant Examination Form).

    A calibrated photographic measurement is taken to assess tongue frenulum's length and width: the tongue was lifted with the examinator's two fingers and a picture of the baby's mouth was taken. A calibration is then used to calculate the length of the frenulum on the picture, using pixelization, by measuring the distance between its origin and insertion. The reliability and reproducibility of these measurements were assessed prior to the study, yielding a Cronbach's alpha of 0.99 and intraclass correlation coefficients (ICC) for interobserver and intraobserver reproducibility of 0.81 and 0.99, respectively.

  3. Muscle tension, joint mobility and cranial asymmetry: evaluated via manual osteopathic palpation and Myoton Pro (© 2016 Myoton AS) measurement on specific muscles (sternocleidomastoid, trapezius, mylohyoid).

B. Maternal assessment:

  • Medical record review (pregnancy, delivery, breastfeeding-related factors).
  • Additional questions related to breastfeeding: previous experience in breastfeeding, duration, reasons for abandoning etc...
  • Assessment of maternal well-being: Edinburgh postnatal depression scale (EPDS)21, visual analogue scale for anxiety and fatigue, as those factors are known to influence breastfeeding duration.

During breastfeeding:

  • observational scales: BSES-SF, IBFAT, NOMAS, LATCH and BBAT.
  • optional videorecording of breastfeeding.
  • breastfeeding pain assessment: VAS and McGill Pain Questionnaire.

T2 : At 6 weeks postpartum, after the medical postnatal exam:

  • Reassessment of tongue function, oral anatomy, calibrated photography and osteopathic findings (same as T1).
  • Breastfeeding evaluation (if continuing) including weight monitoring before/during/after feeding, using OFS-T scale.
  • Additional maternal and infant assessments: reflux symptoms (GSQ-I), EPDS, VAS for fatigue/anxiety, Baxter Infant Questionnaire.
  • Questions about breastfeeding complications: crackled nipples, engorgement, mastitis, abscess, nipple bleeding.

T3 : At 3 months of age: the same evaluation as T2 are conducted in the parent's home.

T4, T5 and T6: At 6 months, 1 year, and 2 years, structured phone interviews are tracking breastfeeding duration, food diversification problems, feeding behaviors, teething, motor and language development, and sleep patterns.

T7 : At 4 years: in-person assessments include lingual frenulum (Coryllos scale, photographic measurements), dental occlusion (baby-ROMA index), speech and language development (Hénin grid, Evalo 2-6, NEEL phonological/articulation test), and parental questionnaires on language and behavior.

02

Conditions studied

  • Ankyloglossia
  • Breastfeeding
  • Breastfeeding Self-Efficacy
  • Breastfeeding Duration
  • Breastfeeding Outcomes

Keywords

  • Prospective study on ankyloglossia
  • ankyloglossia
  • tongue tie
  • ankyloglossia tools
  • ankyloglossia scales
  • ankyloglossia outcomes
  • ankyloglossia breastfeeding
03

In context

Ankyloglossia

32 studies on the registry are indexed under Ankyloglossia; 8 are open to participants now.

Browse Ankyloglossia studies →

Lead sponsor

Erasme University Hospital is the lead sponsor of 181 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 5 Days
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy newborns at the maternity ward of Erasme Hospital, Anderlecht, born between 23/05/2022 and 30/09/2024.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Newborn infant with a gestational age ≥ 37 weeks admitted to the postnatal ward of Hospital Erasmus- 1 to 5 days old
  • Mother intends to breastfeed at the postnatal ward
  • At least one parent has a good understanding of French

Exclusion criteria

Exclusion Criteria:

Newborns will be excluded from the study if they present any of the following:

  • Severe medical conditions, including congenital oropharyngeal malformations (e.g. cleft lip, heart defects or brain anomalies) or Prader-Willi syndrome, sepsis, intrauterine growth restriction, need for intensive care
  • A positive COVID-19 test (for either the newborn or parents)
  • Multiple births (twins, triplets)
  • Parents under psychosocial surveillance
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
348 participants (actual)
Target follow-up
4 Years
Patient registry
Yes

Groups and cohorts

  • Healthy newborns

    Newborns will be followed up and assessed for ankyloglossia using TABBY, ATLFF, LFPI and Coryllos scales

    Other: TABBY · Other: Lingual Frenulum Protocol with Scores for Infants. · Other: Hazelbaker Assessment Tool for Lingual Frenulum Function · Other: Tongue Tie Measurement · Other: Coryllos Scale · Other: Bristol Breastfeeding Assessment Tool · Other: Infant Breastfeeding Assessment Tool · Other: Neonatal Oral-Motor Assessment Scale · Other: LATCH score

  • Breastfeeding mothers

    Other: Breastfeeding Self Efficacy Scale - Short Form · Other: Bristol Breastfeeding Assessment Tool · Other: Infant Breastfeeding Assessment Tool · Other: Neonatal Oral-Motor Assessment Scale · Other: LATCH score · Other: Nipple pain assessment

Interventions

  • OtherTABBY

    Assessment of tongue mobility and tongue tie with the TABBY scale at birth, 6 weeks and 3 months of age .

  • OtherLingual Frenulum Protocol with Scores for Infants.

    Assessment of tongue mobility, function, tongue tie anatomy, nutritive and non nutritive suck using LFPI (Martinelli Scale) at birth, 6 weeks and 3 months of age.

    Also known as: Martinelli

  • OtherHazelbaker Assessment Tool for Lingual Frenulum Function

    Assessment of tongue mobility, function and tongue tie anatomy at birth, 6 weeks and 3 months.

    Also known as: HATLFF

  • OtherTongue Tie Measurement

    A calibrated photographic measurement is taken at birth, 6 weeks and 3 months to assess tongue frenulum's length and width: the tongue was lifted with the examinator's two fingers and a picture of the baby's mouth was taken. A calibration was then used to calculate the length of the frenulum on the picture, using pixelization, by measuring the distance between its origin and insertion

  • OtherCoryllos Scale

    Assessment of the lingual frenulum with the Corollas scale at birth, 6 weeks and 3 months of age

  • OtherBreastfeeding Self Efficacy Scale - Short Form

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the Breastfeeding Self Efficacy Scale - Short Form

    Also known as: BSES-SF

  • OtherBristol Breastfeeding Assessment Tool

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the Bristol Breastfeeding Assessment Tool

  • OtherInfant Breastfeeding Assessment Tool

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the Infant Breastfeeding Assessment Tool

  • OtherNeonatal Oral-Motor Assessment Scale

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the Neonatal Oral-Motor Assessment Scale

  • OtherLATCH score

    Assessment of breastfeeding at birth, 6 weeks, 3 months, with the LATCH-Score

  • OtherNipple pain assessment

    Nipple pain assessment using VAS and the Mc Gill Pain Questionary

06

What researchers measure

Primary outcomes

  1. Breastfeeding duration

    Duration of breastfeeding in days

    Time frame: From enrollment to the end of the study at 4 years

Secondary outcomes

  1. Tongue tie length and growth

    Tongue tie length at birth, 6 weeks and 3 months, measured by calibrated photographic measurement. A calibration was then used to calculate the length of the frenulum on the picture, using pixelization, by measuring the distance between its origin and insertion.

    Time frame: At birth, 6 weeks of age and 3 months of age

  2. Pain during breastfeeding

    pain during breastfeeding at birth, 6 weeks and 3 months, measured by the VAS and Mc Gill Pain Questionary

    Time frame: At birth, 6 weeks of age and 3 months of age

  3. Breastfeeding complications

    Presence of crackled nipples, engorgement, mastitis, nipple bleeding, abscess, at birth, 6 weeks and 3 months.

    Time frame: At birth, 6 weeks of age and 3 months of age

  4. Infant Breastfeeding Assessment Tool

    Breastfeeding assessed by Infant Breastfeeding Assessment Tool (IBFAT): observational breastfeeding score ranging from 0 to 12 (best score: 12)

    Time frame: At birth, 6 weeks of age and 3 months of age

  5. Breastfeding Self-Efficacy Scale - Short Form

    Breastfeeding Self Efficacy ranging from 14 (lower score) to 70 (best score) assessed at birth, at 6 weeks and at 3 months

    Time frame: At birth, 6 weeks of age and 3 months of age

  6. Neonatal Oral Motor Assessment Scale (NOMAS),

    Observational scale scoring oral -motor skill as normal, disorganized or dysfunctional (best score: normal)

    Time frame: At birth, 6 weeks of age and 3 months of age

  7. Breastfeeding assessment: LATCH score

    LATCH score (observational breastfeeding scale) ranging from 0 to 10 (best score: 10)

    Time frame: At birth, 6 weeks of age and 3 months of age

  8. Bristol Breastfeeding Assessment Tool

    Bristol Breastfeeding Assessment Tool (BBAT), observational breatsfeeding scale ranging from 0 to 8 (best score:8).

    Time frame: At birth, 6 weeks of age and 3 months of age

  9. Oro facial praxis- Hénin Grid

    At 4 years: in-person assessments will assess speech with :Hénin grid. This grid has standards (acquired - not acquired).

    Time frame: At the age of 4 years

  10. Feeding behaviors

    feeding behaviors assessed by structured phone interviews at 6 months, 1 year and 2 years of age.

    Time frame: At the age of 6 months, 1 year and 2 years

  11. dental occlusion

    At the age of 4 years dental occlusion will be assessed with the baby-ROMA index.

    Time frame: At the age of 4 years

  12. Orofacial praxies - Evalo 2-6

    This grid has standards (acquired - not acquired)

    Time frame: At the age of 4 years

  13. Speech

    The NEEL phonological/articulation test will be performed by speech therapists. This test has standards (acquired/ not acquired).

    Time frame: At the age of 4 years

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data will be shared upon reasonable request. Requests must include a methodologically sound research proposal and will be reviewed by the study sponsor. Data will be shared under a data use agreement to ensure participant confidentiality.

Supporting information: Study protocol

Time frame: Beginning 6 months after publication. Available for 5 years.

Access criteria: Individual participant data will be shared with researchers who provide a methodologically sound proposal, for purposes related to achieving the aims outlined in the approved proposal and for secondary research analyses.

Data sharing details ↗ · www.erasme.be

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07512765
Collaborators
Université Libre de Bruxelles, King Baudouin Foundation, Fonds Erasme pour la Recherche Médicale
Responsible party
Sponsor
First posted
Apr 6, 2026
Start date
May 23, 2022
Primary completion
Mar 30, 2025
Completion
Dec 31, 2028 (estimated)
Last update
Apr 6, 2026

Study contacts

Laura J Maroye, PhD Student
principal investigator · Université Libre de Bruxelles
Jennifer Foucart, PhD
study director · Université Libre de Bruxelles
Ana Bengoetxea, PhD
study director · Université Libre de Bruxelles

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion